C.ANIRUDH JAGANNADH; M.SRAVANI; DR M.D DHANARAJU. ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS. ijpbs 2013, 4, 750-754.